The global bioreactors market was valued at $2,615.4 million in 2020, and is estimated to reach $7,328.4 million by 2030, growing at a CAGR of 10.7% from 2021 to 2030.
Bioreactors are defined as medical devices, which are designed to produce an effective environment for enzymes or whole cells in order to transform biochemicals into products. Bioreactors are used in various applications such as cell growth, enzyme production, biosensors, milk processing, tissue engineering, protein synthesis, anaerobic digestion, algae production and cell culture production. Bioreactor vessels are also used for bio-molecular synthesizers such as DNA and protein synthesis.
The global bioreactors market is majorly driven by an alarming increase in the prevalence of chronic diseases such as cancer, cardiovascular disease, cystic fibrosis, ulcerative colitis; rise in focus on orphan drug development; rise in demand for monoclonal antibodies; advancements in R&D activities for production of vaccine; and surge in need for cell culture research. For instance, according to the World Health Organization (WHO), in 2020, approximately, 10 million people died due to various types of cancer. As per data published by a Cystic Fibrosis Foundation (CFF), in 2019, a total of 70,000 population in the world was diagnosed with cystic fibrosis and more than 1000 new cases of cystic fibrosis were reported each year. Moreover, the surge in incidences of diseases such as cancer, significantly contributes toward the market growth, owing to the fact that monoclonal antibodies are used in the treatment of several chronic diseases. Bioreactors are also designed to develop culture hybridoma cells for long term continuous production of monoclonal antibodies. Thus, the increase in prevalence of chronic disease and a surge in demand for monoclonal antibodies are the factors expected to propel the growth of the bioreactors market.
Development in biotechnology and pharmaceutical industry and advancement in R&D for cell culture and microbial application are the major factors that drive the growth of the global bioreactors market. Rise in biomedical research activities acts as a key driving force to the global market. Furthermore, governments are taking multiple initiatives to support regenerative medical research, which is expected to boost the market growth. Moreover, in 2021, SingHealth Duke-NUS Academic Medical Centre announced various advanced regenerative medicine and introduced cellular therapy to enhance patient care. The project aims to explore regenerative cell therapy for treatment of blood cancers, heart failure, and eye degeneration. Advancement in the design of bioreactors in order to optimize bioprocessing during drug development, is anticipated to provide lucrative opportunities for the market expansion. For instance, in May 2021, Beckman Coulter Life Sciences, a Danaher Corporation company, launched next-generation Biolector XT Microbioreactor to provide highest flexibility, and enable high throughput strain screening, feeding strategy optimization and monitoring of cell culture cultivation.
On the contrary, high cost of bioreactors is anticipated to hinder the market growth during the forecast period. Furthermore, development in pharmaceutical and biotechnology companies for manufacturing of complex molecules, surge the demand for bioreactors. This encourages many key players to enter emerging markets, thus offering a lucrative growth opportunity in the bioreactors market.
The global bioreactors market is segmented into type, usage, scale, control type and region. By type, the market is categorized into glass, stainless steel, and single-use. By usage, it is divided into lab-scale production, pilot-scale production, and full-scale production. By scale, the market is classified into 5L-20L, 20L-200L, 200L-1500L, and above 1500L. On the basis of control type, the market is categorized into manual and automated (MFCs). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global bioreactors market are BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, and Thermo Fisher Scientific, Inc.
Bioreactors are defined as medical devices, which are designed to produce an effective environment for enzymes or whole cells in order to transform biochemicals into products. Bioreactors are used in various applications such as cell growth, enzyme production, biosensors, milk processing, tissue engineering, protein synthesis, anaerobic digestion, algae production and cell culture production. Bioreactor vessels are also used for bio-molecular synthesizers such as DNA and protein synthesis.
The global bioreactors market is majorly driven by an alarming increase in the prevalence of chronic diseases such as cancer, cardiovascular disease, cystic fibrosis, ulcerative colitis; rise in focus on orphan drug development; rise in demand for monoclonal antibodies; advancements in R&D activities for production of vaccine; and surge in need for cell culture research. For instance, according to the World Health Organization (WHO), in 2020, approximately, 10 million people died due to various types of cancer. As per data published by a Cystic Fibrosis Foundation (CFF), in 2019, a total of 70,000 population in the world was diagnosed with cystic fibrosis and more than 1000 new cases of cystic fibrosis were reported each year. Moreover, the surge in incidences of diseases such as cancer, significantly contributes toward the market growth, owing to the fact that monoclonal antibodies are used in the treatment of several chronic diseases. Bioreactors are also designed to develop culture hybridoma cells for long term continuous production of monoclonal antibodies. Thus, the increase in prevalence of chronic disease and a surge in demand for monoclonal antibodies are the factors expected to propel the growth of the bioreactors market.
Development in biotechnology and pharmaceutical industry and advancement in R&D for cell culture and microbial application are the major factors that drive the growth of the global bioreactors market. Rise in biomedical research activities acts as a key driving force to the global market. Furthermore, governments are taking multiple initiatives to support regenerative medical research, which is expected to boost the market growth. Moreover, in 2021, SingHealth Duke-NUS Academic Medical Centre announced various advanced regenerative medicine and introduced cellular therapy to enhance patient care. The project aims to explore regenerative cell therapy for treatment of blood cancers, heart failure, and eye degeneration. Advancement in the design of bioreactors in order to optimize bioprocessing during drug development, is anticipated to provide lucrative opportunities for the market expansion. For instance, in May 2021, Beckman Coulter Life Sciences, a Danaher Corporation company, launched next-generation Biolector XT Microbioreactor to provide highest flexibility, and enable high throughput strain screening, feeding strategy optimization and monitoring of cell culture cultivation.
On the contrary, high cost of bioreactors is anticipated to hinder the market growth during the forecast period. Furthermore, development in pharmaceutical and biotechnology companies for manufacturing of complex molecules, surge the demand for bioreactors. This encourages many key players to enter emerging markets, thus offering a lucrative growth opportunity in the bioreactors market.
The global bioreactors market is segmented into type, usage, scale, control type and region. By type, the market is categorized into glass, stainless steel, and single-use. By usage, it is divided into lab-scale production, pilot-scale production, and full-scale production. By scale, the market is classified into 5L-20L, 20L-200L, 200L-1500L, and above 1500L. On the basis of control type, the market is categorized into manual and automated (MFCs). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global bioreactors market are BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, and Thermo Fisher Scientific, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global bioreactors market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global bioreactors market.
KEY MARKET SEGMENTS
By Type
- Glass
- Stainless Steel
- Single-Use
By Usage
- Lab-Scale Production
- Pilot-Scale Production
- Full-Scale Production
By Scale
- 5L-20L
- 20L-200L
- 200L-1500L
- Above 1500L
By Control Type
- Manual
- Automated
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- BBI-Biotech GmbH
- Bioengineering AG
- Danaher Corporation
- Eppendorf AG
- Getinge
- Infors HT
- Merck KGAA
- Sartorius AG
- Solaris Biotech Solutions
- Thermo Fisher Scientific, Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Advancements in R&D activities for novel biologic and microbial application
3.5.1.2. Rise in technological development for advanced bioreactors
3.5.1.3. Increase in demand for single-use bioreactors
3.5.2. Restraint
3.5.2.1. High cost of bioreactors
3.5.3. Opportunity
3.5.3.1. Increase in the development of biotechnology and pharmaceutical industry
3.5.4. Impact analysis
3.6. Impact analysis of COVID-19 on the bioreactors market
CHAPTER 4: BIOREACTORS MARKET , BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Single-Use
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market analysis, by Usage
4.3. Stainless steel
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Market analysis, by Usage
4.4. Glass
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.4. Market analysis, by Usage
CHAPTER 5: BIOREACTORS MARKET , BY USAGE
5.1. Overview
5.1.1. Market size and forecast
5.3. Pilot-scale production
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.4. Full-scale production
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
5.5. Lab-scale production
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market analysis, by country
CHAPTER 6: BIOREACTORS MARKET , BY SCALE
6.1. Overview
6.1.1. Market size and forecast
6.2.5L-20L
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3.20L-200L
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4.200L-1500L
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
6.5. Above 1500L
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market analysis, by country
CHAPTER 7: BIOREACTORS MARKET , BY CONTROL TYPE
7.1. Overview
7.1.1. Market size and forecast
7.2. Automated
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market analysis, by country
7.3. Manual
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market analysis, by country
CHAPTER 8: BIOREACTORS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. North America bioreactors market, by type
8.2.3. North America bioreactors market, by usage
8.2.4. North America bioreactors market, by scale
8.2.5. North America bioreactors market, by control type
8.2.6. Market size and forecast, by country
8.2.6.1. U. S.
8.2.6.1.1. U. S. bioreactors market, by type
8.2.6.1.2. U. S. bioreactors market, by usage
8.2.6.1.3. U. S. bioreactors market, by scale
8.2.6.1.4. U. S. bioreactors market, by control type
8.2.6.2. Canada
8.2.6.2.1. Canada bioreactors market, by type
8.2.6.2.2. Canada bioreactors market, by usage
8.2.6.2.3. Canada bioreactors market, by scale
8.2.6.2.4. Canada bioreactors market, by control type
8.2.6.3. Mexico
8.2.6.3.1. Mexico bioreactors market, by type
8.2.6.3.2. Mexico bioreactors market, by usage
8.2.6.3.3. Mexico bioreactors market, by scale
8.2.6.3.4. Mexico bioreactors market, by control type
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Europe bioreactors market, by type
8.3.3. Europe bioreactors market, by usage
8.3.4. Europe bioreactors market, by scale
8.3.5. Europe bioreactors market, by control type
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Germany bioreactors market, by type
8.3.6.1.2. Germany bioreactors market, by usage
8.3.6.1.3. Germany bioreactors market, by scale
8.3.6.1.4. Germany bioreactors market, by control type
8.3.6.2. France
8.3.6.2.1. France bioreactors market, by type
8.3.6.2.2. France bioreactors market, by usage
8.3.6.2.3. France bioreactors market, by scale
8.3.6.2.4. France bioreactors market, by control type
8.3.6.3. UK
8.3.6.3.1. UK bioreactors market, by type
8.3.6.3.2. UK bioreactors market, by usage
8.3.6.3.3. UK bioreactors market, by scale
8.3.6.3.4. UK bioreactors market, by control type
8.3.6.4. Italy
8.3.6.4.1. Italy bioreactors market, by type
8.3.6.4.2. Italy bioreactors market, by usage
8.3.6.4.3. Italy bioreactors market, by scale
8.3.6.4.4. Italy bioreactors market, by control type
8.3.6.5. Spain
8.3.6.5.1. Spain bioreactors market, by type
8.3.6.5.2. Spain bioreactors market, by usage
8.3.6.5.3. Spain bioreactors market, by scale
8.3.6.5.4. Spain bioreactors market, by control type
8.3.6.6. Rest of Europe
8.3.6.6.1. Rest of Europe bioreactors market, by type
8.3.6.6.2. Rest of Europe bioreactors market, by usage
8.3.6.6.3. Rest of Europe bioreactors market, by scale
8.3.6.6.4. Rest of Europe bioreactors market, by control type
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Asia-Pacific bioreactors market, by type
8.4.3. Asia-Pacific bioreactors market, by usage
8.4.4. Asia-Pacific bioreactors market, by scale
8.4.5. Asia-Pacific bioreactors market, by control type
8.4.6. Market size and forecast, by country
8.4.6.1. China
8.4.6.1.1. China bioreactors market, by type
8.4.6.1.2. China bioreactors market, by usage
8.4.6.1.3. China bioreactors market, by scale
8.4.6.1.4. China bioreactors market, by control type
8.4.6.2. Japan
8.4.6.2.1. Japan bioreactors market, by type
8.4.6.2.2. Japan bioreactors market, by usage
8.4.6.2.3. Japan bioreactors market, by scale
8.4.6.2.4. Japan bioreactors market, by control type
8.4.6.3. India
8.4.6.3.1. India bioreactors market, by type
8.4.6.3.2. India bioreactors market, by usage
8.4.6.3.3. India bioreactors market, by scale
8.4.6.3.4. India bioreactors market, by control type
8.4.6.4. Australia
8.4.6.4.1. Australia bioreactors market, by type
8.4.6.4.2. Australia bioreactors market, by usage
8.4.6.4.3. Australia bioreactors market, by scale
8.4.6.4.4. Australia bioreactors market, by control type
8.4.6.5. South Korea
8.4.6.5.1. South Korea bioreactors market, by type
8.4.6.5.2. South Korea. bioreactors market, by usage
8.4.6.5.3. South Korea bioreactors market, by scale
8.4.6.5.4. South Korea bioreactors market, by control type
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Rest of Asia-Pacific bioreactors market, by type
8.4.6.6.2. Rest of Asia-Pacific bioreactors market, by usage
8.4.6.6.3. Rest of Asia-Pacific bioreactors market, by scale
8.4.6.6.4. Rest of Asia-Pacific bioreactors market, by control type
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. LAMEA bioreactors market, by type
8.5.3. LAMEA bioreactors market, by usage
8.5.4. LAMEA bioreactors market, by scale
8.5.5. LAMEA bioreactors market, by control type
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Brazil bioreactors market, by type
8.5.6.1.2. Brazil bioreactors market, by usage
8.5.6.1.3. Brazil bioreactors market, by scale
8.5.6.1.4. Brazil bioreactors market, by control type
8.5.6.2. Saudi Arabia
8.5.6.2.1. Saudi Arabia bioreactors market, by type
8.5.6.2.2. Saudi Arabia bioreactors market, by usage
8.5.6.2.3. Saudi Arabia bioreactors market, by scale
8.5.6.2.4. Saudi Arabia bioreactors market, by control type
8.5.6.3. South Africa
8.5.6.3.1. South Africa bioreactors market, by type
8.5.6.3.2. South Africa bioreactors market, by usage
8.5.6.3.3. South Africa bioreactors market, by scale
8.5.6.3.4. South Africa bioreactors market, by control type
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Rest of LAMEA bioreactors market, by type
8.5.6.4.2. Rest of LAMEA bioreactors market, by usage
8.5.6.4.3. Rest of LAMEA bioreactors market, by scale
8.5.6.4.4. Rest of LAMEA bioreactors market, by control type
CHAPTER 9: COMPANY PROFILES
9.1. BBI-BIOTECH GmbH
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.2. BIOENGINEERING AG.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.3. DANAHER CORPORATION
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. EPPENDORF AG
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. GETINGE
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. INFORS HT
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Key strategic moves and developments
9.7. MERCK KGAA
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. SARTORIUS AG
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments
9.9. SOLARIS BIOTECH SOLUTIONS
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.10. THERMO FISHER SCIENTIFIC, INC.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developmentsLIST OF TABLES
TABLE 01. GLOBAL BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02. BIOREACTORS MARKET FOR SINGLE-USE, BY REGION, 2020-2030 ($MILLION)
TABLE 03. BIOREACTORS MARKET FOR SINGLE-USE, BY USAGE, 2020-2030 ($MILLION)
TABLE 04. BIOREACTORS MARKET FOR STAINLESS STEEL, BY REGION, 2020-2030 ($MILLION)
TABLE 05. BIOREACTORS MARKET FOR STAINLESS STEEL, BY USAGE, 2020-2030 ($MILLION)
TABLE 06. BIOREACTORS MARKET FOR GLASS, BY REGION, 2020-2030 ($MILLION)
TABLE 07. BIOREACTORS MARKET FOR GLASS, BY USAGE, 2020-2030 ($MILLION)
TABLE 08. GLOBAL BIOREACTORS MARKET , BY USAGE, 2020-2030 ($MILLION)
TABLE 09. BIOREACTORS MARKET FOR PILOT-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 10. BIOREACTORS MARKET FOR FULL-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 11. BIOREACTORS MARKET FOR LAB-SCALE PRODUCTION, BY REGION, 2020-2030 ($MILLION)
TABLE 12. GLOBAL BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 13. BIOREACTORS MARKET FOR 5L-20 L, BY REGION, 2020-2030 ($MILLION)
TABLE 14. BIOREACTORS MARKET FOR 20 L-200 L, BY REGION, 2020-2030 ($MILLION)
TABLE 15. BIOREACTORS MARKET FOR 200 L-1500 L, BY REGION, 2020-2030 ($MILLION)
TABLE 16. BIOREACTORS MARKET FOR ABOVE 1500 L, BY REGION, 2020-2030 ($MILLION)
TABLE 17. GLOBAL BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 18. BIOREACTORS MARKET FOR AUTOMATED, BY REGION, 2020-2030 ($MILLION)
TABLE 19. BIOREACTORS MARKET FOR MANUAL, BY REGION, 2020-2030 ($MILLION)
TABLE 20. BIOREACTORS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 21. NORTH AMERICA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 22. NORTH AMERICA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 23. NORTH AMERICA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 24. NORTH AMERICA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 25. NORTH AMERICA BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 26. U.S. BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 27. U.S. BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 28. U.S. BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 29. U.S. BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 30. CANADA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 31. CANADA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 32. CANADA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 33. CANADA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 34. MEXICO BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 35. MEXICO BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 36. MEXICO BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 37. MEXICO BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 38. EUROPE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 39. EUROPE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 40. EUROPE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 41. EUROPE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 42. EUROPE BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 43. GERMANY BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 44. GERMANY BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 45. GERMANY BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 46. GERMANY BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 47. FRANCE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 48. FRANCE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 49. FRANCE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 50. FRANCE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 51. UK BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 52. UK BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 53. UK BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 54. UK BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 55. ITALY BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 56. ITALY BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 57. ITALY BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 58. ITALY BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 59. SPAIN BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 60. SPAIN BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 61. SPAIN BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 62. SPAIN BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 63. REST OF EUROPE BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 64. REST OF EUROPE BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 65. REST OF EUROPE BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 66. REST OF EUROPE BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 67. ASIA-PACIFIC BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 68. ASIA-PACIFIC BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 69. ASIA-PACIFIC BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 70. ASIA-PACIFIC BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 71. ASIA-PACIFIC BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 72. CHINA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 73. CHINA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 74. CHINA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 75. CHINA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 76. JAPAN BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 77. JAPAN BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 78. JAPAN BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 79. JAPAN BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 80. INDIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 81. INDIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 82. INDIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 83. INDIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 84. AUSTRALIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 85. AUSTRALIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 86. AUSTRALIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 87. AUSTRALIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 88. SOUTH KOREA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 89. SOUTH KOREA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 90. SOUTH KOREA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 91. SOUTH KOREA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 93. REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 94. REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 95. REST OF ASIA-PACIFIC BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 96. LAMEA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 97. LAMEA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 98. LAMEA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 99. LAMEA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 100. LAMEA BIOREACTORS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 101. BRAZIL BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 102. BRAZIL BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 103. BRAZIL BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 104. BRAZIL BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 105. SAUDI ARABIA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 106. SAUDI ARABIA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 107. SAUDI ARABIA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 108. SAUDI ARABIA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 109. SOUTH AFRICA BIOREACTORS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 110. SOUTH AFRICA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 111. SOUTH AFRICA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 112. SOUTH AFRICA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 113. REST OF LAMEA BIOREACTORS MARKET, BY USAGE, 2020-2030 ($MILLION)
TABLE 114. REST OF LAMEA BIOREACTORS MARKET, BY SCALE, 2020-2030 ($MILLION)
TABLE 115. REST OF LAMEA BIOREACTORS MARKET, BY CONTROL TYPE, 2020-2030 ($MILLION)
TABLE 116. BBI: COMPANY SNAPSHOT
TABLE 117. BBI: OPERATING SEGMENTS
TABLE 118. BBI: PRODUCT PORTFOLIO
TABLE 119. BIOENGINEERING: COMPANY SNAPSHOT
TABLE 120. BIOENGINEERING: OPERATING BUSINESS SEGMENTS
TABLE 121. BIOENGINEERING: PRODUCT PORTFOLIO
TABLE 122. DANAHER: COMPANY SNAPSHOT
TABLE 123. DANAHER: PRODUCT SEGMENTS
TABLE 124. DANAHER: PRODUCT PORTFOLIO
TABLE 125. DANAHER: KEY DEVELOPMENTS
TABLE 126. EPPENDORF: COMPANY SNAPSHOT
TABLE 127. EPPENDORF: OPERATING SEGMENTS
TABLE 128. EPPENDORF: PRODUCT PORTFOLIO
TABLE 129. EPPENDORF: KEY DEVELOPMENTS
TABLE 130. GETINGE: COMPANY SNAPSHOT
TABLE 131. GETINGE: OPERATING BUSINESS SEGMENTS
TABLE 132. GETINGE: PRODUCT PORTFOLIO
TABLE 133. GETINGE: KEY DEVELOPMENTS
TABLE 134. INFORS: COMPANY SNAPSHOT
TABLE 135. INFORS: OPERATING SEGMENTS
TABLE 136. INFORS: PRODUCT PORTFOLIO
TABLE 137. INFORS: KEY DEVELOPMENTS
TABLE 138. MERCK: COMPANY SNAPSHOT
TABLE 139. MERCK: OPERATING SEGMENTS
TABLE 140. MERCK: PRODUCT PORTFOLIO
TABLE 141. MERCK: KEY DEVELOPMENTS
TABLE 142. SARTORIUS: COMPANY SNAPSHOT
TABLE 143. SARTORIUS: PRODUCT SEGMENTS
TABLE 144. SARTORIUS: PRODUCT PORTFOLIO
TABLE 145. SARTORIUS: KEY DEVELOPMENTS
TABLE 146. SOLARIS: COMPANY SNAPSHOT
TABLE 147. SOLARIS: PRODUCT SEGMENTS
TABLE 148. SOLARIS: PRODUCT PORTFOLIO
TABLE 149. THERMO FISHER: COMPANY SNAPSHOT
TABLE 150. THERMO FISHER: OPERATING SEGMENTS
TABLE 151. THERMO FISHER: PRODUCT PORTFOLIO
TABLE 152. THERMO FISHER: KEY DEVELOPMENTSLIST OF FIGURES
FIGURE 01. BIOREACTORS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR SINGLE-USE, BY COUNTRY, 2020-2030 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR STAINLESS STEEL, BY COUNTRY, 2020-2030 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR GLASS, BY COUNTRY, 2020-2030 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR PILOT-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR FULL-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR LAB-SCALE PRODUCTION, BY COUNTRY, 2020-2030 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 5L-20L, BY COUNTRY, 2020-2030 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 20L-200L, BY COUNTRY, 2020-2030 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR 200L-1500L, BY COUNTRY, 2020-2030 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR ABOVE 1500, BY COUNTRY, 2020-2030 (%)
FIGURE 23. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR AUTOMATED, BY COUNTRY, 2020-2030 (%)
FIGURE 24. COMPARATIVE ANALYSIS OF BIOREACTORS MARKET FOR MANUAL, BY COUNTRY, 2020-2030 (%)
FIGURE 25. DANAHER: NET SALES, 2018-2020 ($MILLION)
FIGURE 26. DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27. DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 28. EPPENDORF: NET SALES, 2018-2020 ($MILLION)
FIGURE 29. EPPENDORF: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30. EPPENDORF: REVENUE SHARE BY REGION, 2020(%)
FIGURE 31. GETINGE: NET SALES, 2018-2020 ($MILLION)
FIGURE 32. GETINGE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33. GETINGE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34. MERCK: NET SALES, 2018-2020 ($MILLION)
FIGURE 35. MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36. MERCK: REVENUE SHARE BY REGION, 2020(%)
FIGURE 37. SARTORIUS: NET SALES, 2018-2020 ($MILLION)
FIGURE 38. SARTORIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39. SARTORIUS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40. THERMO FISHER: NET SALES, 2018-2020 ($MILLION)
FIGURE 41. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42. THERMO FISHER: REVENUE SHARE BY REGION, 2020(%)
Companies Mentioned
- BBI-Biotech GmbH
- Bioengineering AG
- Danaher Corporation
- Eppendorf AG
- Getinge
- Infors HT
- Merck KGAA
- Sartorius AG
- Solaris Biotech Solutions
- Thermo Fisher Scientific Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 277 |
| Published | July 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 2615.4 million |
| Forecasted Market Value ( USD | $ 7328.4 million |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
